Zeprumetostat Tablets: Clinical Trials

2 trials of Zeprumetostat Tablets, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Not yet recruiting 2

Follow Zeprumetostat Tablets: new trials by email Literature Review of Zeprumetostat Tablets trials Research Report on Zeprumetostat Tablets

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Prospective Clinical Study of Zeprumetosta in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma
Zeprumetostat Tablets - Cutaneous T-Cell Lymphoma/Mycosis Fungoides/Sézary Syndrome
Phase 2Not yet recruitingPeking University First Hospital332026-10-312026-10-02
Retlirafusp Alfa Combined With Zeprumetostat, Apatinib, and Chemotherapy as First-Line Treatment for Metastatic GC/GEJC
Retlirafusp alfa, zeprumetostat, apatinib - Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
Phase 2Not yet recruitingFudan University552026-10-012026-10-14

Conditions studied

Lymphoma, T-Cell, Cutaneous (1)  ·  Stomach Neoplasms (1)

Sponsors

Fudan University (1)  ·  Peking University First Hospital (1)

Countries

China (1)